ERBB4

(v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian))

 

  • Alias                                 (According to NCBI)

 

  • HER4,
  • MGC138404,
  • p180erbB4
  • avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 4;
  • receptor tyrosine-protein kinase erbB-4;
  • tyrosine kinase-type cell surface receptor HER4;
  • v-erb-a avian erythroblastic leukemia viral oncogene homolog-like 4;
  • v-erb-a erythroblastic leukemia viral oncogene homolog 4Z
  • Specifically binds and is activated by neuregulins, NRG-2, NRG-3, heparin-binding EGF-like growth factor, betacellulin and NTAK. Interaction with these factors induces cell differentiation. Not activated by EGF, TGF-A, and amphiregulin.
  • Location: 2q33.3-q34
  • Size:1162911bp
  • exons: 14
  • DNA sequence (Human): NC_000002.10

  • CGH (2q33.3):  Losses (%) -6.7   Gain (%)  7.3  

  • Mutations and SNPs (According to HGMD and SNP)

 

 

  • m-RNA                       (According to NCBI and CGAP)

 

  • mRNA sequence (Human): transcript variant JM-a/CVT-1: NM_005235.2

  • transcript variant JM-a/CVT-2: NM_001042599.1
  • Size:  transcript variant JM-a/CVT-1: 11941 bp

  • transcript variant JM-a/CVT-2:  11893 bp 
  • cDNA libraries:

  • Size: 1308 amino acids: 146808 Da
  • Catalytic activity: ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.
  • Subcellular location: Membrane; Single-pass type I membrane protein.

  • Protein domains

     

  • Protein sequence (Human): Q15303

  • Homologous genes:  21084

  • 2D PAGE:

  • 3D Structure:  2AHX 3BBT 3BBW  3BCE

  • PTM: Ligand-binding increases phosphorylation on tyrosine residues. erbb4

 

  • Pathway:

     KEgg  hsa04012  ErbB signaling pathway
     Kegg  hsa04020  Calcium signaling pathway
     Kegg  hsa04320  Dorso-ventral axis formation

            BioCarta    g-Secretase mediated ErbB4 Signaling Pathway

                BioCarta   Role of ERBB2 in Signal Transduction and Oncology

  • Protein interactions: ERBB4

  • Clinical                            (According to OMIM, PubMed)